Zhen Meng
Impact in
-
- Temporomandibular Joint Disorders
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
Papers in
-
- RNA modifications and cancer 8
- RNA Research and Splicing 4
- Epigenetics and DNA Methylation 3
-
- Cancer-related molecular mechanisms research 10
- MicroRNA in disease regulation 7
- Co-authors
- Xiaoxing Kou (6 shared papers)Yehua Gan (5 shared papers)Rui-Yun Bi (5 shared papers)Ye-Hua Gan (5 shared papers)Yanheng Zhou (5 shared papers)Kai Xu (9 shared papers)Xiaolin Niu (1 shared paper)Ning Ning (1 shared paper)
- Journals
- PLoS ONE (4 papers)Oncology Reports (4 papers)Medicine (3 papers)Scientific Reports (3 papers)American Journal of Translational Research (2 papers)
- Partner nations
- ChinaUnited StatesRussia
In The Last Decade
Zhen Meng
58 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 107
- Complementary and Manual Therapy 115
- Cancer Research 350
- Rheumatology 130
- Molecular Biology 550
- Oncology 163
Countries citing papers authored by Zhen Meng
This map shows the geographic impact of Zhen Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhen Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhen Meng more than expected).
Fields of papers citing papers by Zhen Meng
This network shows the impact of papers produced by Zhen Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhen Meng. The network helps show where Zhen Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Zhen Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 63 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 144 | |
| 2 | 2010 | 134 | |
| 3 | 2012 | 116 | |
| 4 | Biallelic inactivation of the thyroid hormone receptor beta1 gene in early stage breast cancer. | 2002 | 82 |
| 5 | 2014 | 62 | |
| 6 | 2013 | 59 | |
| 7 | 2015 | 57 | |
| 8 | Increased risk of local recurrence is associated with allelic loss in normal lobules of breast cancer patients. | 2002 | 56 |
| 9 | 2014 | 54 | |
| 10 | 2012 | 50 | |
| 11 | 2017 | 49 | |
| 12 | 2022 | 48 | |
| 13 | 2017 | 33 | |
| 14 | 2023 | 30 | |
| 15 | 2018 | 24 | |
| 16 | 2020 | 24 | |
| 17 | 2015 | 23 | |
| 18 | 2017 | 23 | |
| 19 | 2018 | 22 | |
| 20 | Genome-wide allelotyping of a new in vitro model system reveals early events in breast cancer progression. | 2002 | 22 |
About Zhen Meng
Zhen Meng is a scholar working on Molecular Biology, Cancer Research, Oncology, Pathology and Forensic Medicine and Pulmonary and Respiratory Medicine, having authored 63 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (10 papers), RNA modifications and cancer (8 papers), MicroRNA in disease regulation (7 papers), RNA Research and Splicing (4 papers), Ferroptosis and cancer prognosis (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Epigenetics and DNA Methylation (3 papers) and Cancer-related Molecular Pathways (3 papers). The work is most often cited by research in Complementary and Manual Therapy (115 citations), Cancer Research (350 citations), Rheumatology (130 citations), Molecular Biology (550 citations) and Oncology (163 citations). Zhen Meng has collaborated with scholars based in China, United States and Russia. Frequent co-authors include Xiaoxing Kou, Yehua Gan, Rui-Yun Bi, Ye-Hua Gan, Yanheng Zhou, Kai Xu, Xiaolin Niu, Ning Ning, Shanaz H. Dairkee and Guang Hao. Their work appears in journals such as PLoS ONE, Oncology Reports, Medicine, Scientific Reports and American Journal of Translational Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.